Suchergebnisse - (Subject:"O3J8G9O825")

PubPharm (6)

1

Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV) : an open-label, phase 2, randomised, controlled, adaptive trial

enthalten in: The Lancet. Infectious diseases | 2024

von Schilling, W. | Jittamala, P. | Watson, J. | +89

ErratumIn: Lancet Infect Dis. 2023 Dec;23(12):e511. - PMID 37839427

2

Virological and clinical rebounds of COVID-19 soon after nirmatrelvir/ritonavir discontinuation

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Antonelli, G. | Focosi, D. | Turriziani, O. | +6

ErratumIn: Clin Microbiol Infect. 2023 Dec 14;:. - PMID 38103639

3

An open-label, randomized, single intravenous dosing study to investigate the effect of fixed-dose combinations of tenofovir/lamivudine or atazanavir/ritonavir on the pharmacokinetics of remdesivir in Ugandan healthy volunteers (RemTLAR)

enthalten in: Trials | 2021

von Walimbwa, S. | Kaboggoza, J. | Waitt, C. | +3

4

Drug-induced liver injury associated with lopinavir-ritonavir in patients with COVID-19 : a disproportionality analysis of U.S. food and drug administration adverse event reporting system (FAERS) data

enthalten in: International journal of clinical pharmacy | 2021

von Tang, H. | Zhou, L. | Li, X. | +5

5

Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China

enthalten in: Journal of medical virology | 2020

von Zhu, F. | Cao, Y. | Xu, S. | +1

CommentIn: J Med Virol. 2020 Sep;92(9):1415. - PMID 32220066

6

Antiretroviral drugs in severe acute respiratory syndrome

enthalten in: Presse medicale (Paris, France : 1983) | 2006

von Yazdanpanah, Y. | Guéry, B.

1
[1]